Griseofulvin, an oral antifungal agent, suppresses hepatitis C virus replication in vitro

Hepatology Research

Volumn 38, Issue 9, 2008, Pages 909-918

  Jin, Haofan ^a   Yamashita, Atsuya ^a   Maekawa, Shinya ^a   Yang, Pinting ^a,b   He, Limin ^a   Takayanagi, Satoru ^a   Wakita, Takaji ^c   Sakamoto, Naoya ^d   Enomoto, Nobuyuki ^a   Ito, Masahiko ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Cell cycle; Griseofulvin; Hepatitis C virus internal ribosome entry site; Hepatitis C virus replicon; JFH 1

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION; VIRUS REPLICATION;

EID: 48949104389     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00352.x     Document Type: Article

References (30)

1. Alter HJ, Purcell RH, Shih JW et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494-500.
2. Choo QL, Kuo G, Weiner AJ et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
3. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26: 62S-5S.
4. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.
5. Lohmann V, Korner F, Koch J et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110-13.
6. Kim SS, Peng LF, Lin W et al. A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication. Gastroenterology 2007; 132: 311-20.
7. Tanabe Y, Sakamoto N, Enomoto N et al. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha. J Infect Dis 2004; 189: 1129-39.
8. Yokota T, Sakamoto N, Enomoto N et al. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep 2003; 4: 602-8.
9. Lindenbach BD, Evans MJ, Syder AJ et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309: 623-6.
10. Wakita T, Pietschmann T, Kato T et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791-6.
11. Zhong J, Gastaminza P, Cheng G et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005; 102: 9294-9.
12. Hinrichsen H, Benhamou Y, Wedemeyer H et al. Short-term antiviral efficacy of BILN 2061a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients. Gastroenterology 2004; 127: 1347-55.
13. Lamarre D, Anderson PC, Bailey M et al. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 2003; 426: 186-9.
14. Reesink HW, Zeuzem S, Weegink CJ et al. Rapid decline of viral RNA in hepatitis C patients treated with VX-950: A phase Ib, placebo-controlled, randomized study. Gastroenterology 2006; 131: 997-1002.
15. Sarrazin C, Rouzier R, Wagner F et al. SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders. Gastroenterology 2007; 132: 1270-8.
16. Amemiya F, Maekawa S, Itakura Y et al. Targeting lipid metabolism in the treatment of hepatitis C. J Infect Dis 2008; 197: 361-70.
17. Martell M, Gomez J, Esteban JI et al. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol 1999; 37: 327-32.
18. Okada Y, Osada M, Kurata S et al. p53 gene family p51 (p63)-encoded, secondary transactivator p51B (TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation. Exp Cell Res 2002; 276: 194-200.
19. Chou TC, Talaly P. A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J Biol Chem 1977; 252: 6438-42.
20. Kitamura T, Koshino Y, Shibata F et al. Retrovirus-mediated gene transfer and expression cloning: Powerful tools in functional genomics. Exp Hematol 2003; 31: 1007-14.
21. Morita S, Kojima T, Kitamura T. Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther 2000; 7: 1063-6.
22. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290: 1972-4.
23. Frese M, Pietschmann T, Moradpour D et al. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 2001; 82: 723-3.
24. Ho YS, Duh JS, Jeng JH et al. Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. Int J Cancer 2001; 91: 393-401.
25. Bost AG, Venable D, Liu L et al. Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system. J Virol 2003; 77: 4401-8.
26. Honda M, Kaneko S, Matsushita E et al. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 2000; 118: 152-62.
27. Venkatesan A, Sharma R, Dasgupta A. Cell cycle regulation of hepatitis C and encephalomyocarditis virus internal ribosome entry site-mediated translation in human embryonic kidney 293 cells. Virus Res 2003; 94: 85-95.
28. Nelson HB, Tang H. Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression. J Virol 2006; 80: 1181-90.
29. Scholle F, Li K, Bodola F, Ikeda M et al. Virus-host cell interactions during hepatitis C virus RNA replication: Impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis. J Virol 2004; 78: 1513-24.
30. Panda D, Rathinasamy K, Santra MK et al. Kinetic suppression of microtubule dynamic instability by griseofulvin: Implications for its possible use in the treatment of cancer. Proc Natl Acad Sci USA 2005; 102: 9878-83.